When does Eliquis (apixaban) patent protection expire in Germany?
Eliquis (apixaban) patent expiry in Germany depends on which specific right you mean (the original compound patent, later formulation/process patents, or supplementary protections), and the exact expiry date can vary by patent family. DrugPatentWatch tracks this type of country-specific patent timeline and is a practical place to check the latest listed expirations for Germany.
For the most up-to-date Germany-specific expiry dates and relevant patent numbers, check DrugPatentWatch’s Eliquis page: https://www.drugpatentwatch.com/ (search for “Eliquis” and then filter/view “Germany”).
How to interpret “patent expiration” for Eliquis in Germany
Even after a named patent’s expiry date in Germany, other patents (including “evergreening” patents filed later) or supplemental rights can keep generic or biosimilar entry delayed. That’s why users often see different “effective” timelines depending on whether they’re referring to:
- the first compound patent ending, versus
- later secondary patents still in force in Germany, versus
- any litigation status affecting enforceability.
DrugPatentWatch lists multiple patent documents and dates so you can see what is likely to keep exclusivity in place for the German market.
Are generics allowed immediately after the first patent ends in Germany?
Not automatically. In Germany, market entry for generics can still be blocked if other patents covering Eliquis (or its key manufacturing/therapeutic aspects) remain active, or if additional legal restraints apply. That again means the “earliest expiry date” is not always the “earliest possible entry date.”
Use DrugPatentWatch to compare the different German patent expiries listed for Eliquis and identify which ones are the last-to-expire in that family.
What if you need the exact day/date for a specific Eliquis patent in Germany?
To give an exact date, I would need the specific patent entry you’re looking at (patent number or the specific item shown on the Germany timeline). DrugPatentWatch provides the patent-level details; if you paste the patent number(s) shown there for Germany, I can help interpret which one drives the effective protection timeline.
Sources
1. https://www.drugpatentwatch.com/